In this episode of SCRS Talks, Jimmy Bechtel sits down with Sean Stanton, Founder and CEO of K2 Medical Research, and Christian Burns, Founder and President of Populus Health, to explore how their two organizations are working together to advance CNS drug development. With decades of combined experience across psychiatry, neurology, and neurodegeneration, Sean and Christian discuss what makes CNS trials uniquely challenging, what it takes to earn and maintain trust with sponsors and CRO...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from SCRS Talks
How Agentic AI Is Transforming Clinical Research Site Operations
Features of Study Feasibility Technology
The Missing Voice in AI Drug Development
AI at Your Site: Compliance and What It Takes
Get summaries like this every morning.
Free AI-powered recaps of SCRS Talks and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.